| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8603ee14f13e9c3d3f6d5858bf4f3bf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2017-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b92e917755637cb1ab3624c25045494
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce9e1d600ec2f18d2ed862e72abf61ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecc719557dba036de63fa63164d449f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fdc5e74db22cbc5689e9cd25cf54f54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f51c150d52bf05d3adc595dec30aeb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f10d33972d31454b0466c1b4031d4f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66b4d74b4ac463cce21aa59b7cbb7607 |
| publicationDate |
2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10696675-B2 |
| titleOfInvention |
Imidazopyridopyrimidine derivative compound and use thereof |
| abstract |
A novel imidazopyridine derivative compound and uses thereof are disclosed. An imidazopyridopyridine derivative compound of Chemical Formula 1 having selective inhibitory activity for a fibroblast growth factor receptor (FGFR) and a pharmaceutical composition including the compound are disclosed: |
| priorityDate |
2016-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |